Liminatus Pharma, Inc. (LIMN)

NASDAQ: LIMN · Real-Time Price · USD

0.9701

-0.0099 (-1.01%)

At close: Dec 4, 2025, 4:00 PM EST

1.010

+0.057 (5.98%)

Pre-market: Dec 5, 2025, 6:00 AM EST

Liminatus Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 4, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	26	80	75	349	337
Market Cap Growth	-65.91%	6.12%	-78.38%	3.48%	-
Enterprise Value	27	97	87	-	-
Last Close Price	0.95	11.22	10.33	10.12	9.78
PB Ratio	-	-4.14	-4.78	-32.30	-29.64
Debt / Equity Ratio	-0.88	-1.03	-1.02	-1.53	-1.16
Quick Ratio	0.25	0.00	0.03	0.29	0.00
Current Ratio	0.42	0.21	0.12	0.39	0.19
Return on Assets (ROA)	-48.06%	-54.41%	-66.30%	-35.51%	-
Return on Capital (ROIC)	-	-468.22%	-101.31%	-45.20%	-
Return on Capital Employed (ROCE)	147.90%	17.20%	30.50%	25.10%	35.10%
Earnings Yield	-8.79%	-4.43%	-6.60%	-0.84%	-1.66%
Buyback Yield / Dilution	-181.69%	-9.49%	-188.25%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q